Citation 93232

MARTIN,JR: EGAN,RS: GOLDSTEIN,AW: COLLUM,P:. (1975). EXTENSION OF THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY. ISOLATION AND STRUCTURE OF ERYTHROMYCIN E.. 31()

Citation Details

Title	EXTENSION OF THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY. ISOLATION AND STRUCTURE OF ERYTHROMYCIN E.
Authors	MARTIN,JR: EGAN,RS: GOLDSTEIN,AW: COLLUM,P:
Year	1975
Volume	31
Issue

Summary

Year: 1975

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces erythreus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	ACTIVE
2	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	ACTIVE
3	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
4	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
5	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	ACTIVE
6	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
7	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
8	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
9	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	ACTIVE
10	ANTIBACTERIAL ACTIVITY	ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYCHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS MORE THAN 100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN E	INACTIVE
11	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
12	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
13	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
14	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	INACTIVE
15	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	INACTIVE
16	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
17	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
18	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE
19	ANTIBACTERIAL ACTIVITY	CHEMICAL CONVERSION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMICROBIAL TRANSFORMATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERYTHROMYCIN A	ACTIVE

Show SPARQL Queries (1)